---

Mucormycosis and its implication in COVID-19

---

Editorial

Author Details : Aseem Setia, Sankha Bhattacharya*

Volume : 8, Issue : 2, Year : 2021

Article Page : 97-99

https://doi.org/10.18231/j.ijpp.2021.016

Suggest article by email

Get Permission

---

Abstract

Mucormycosis is a life-threatening fungal infection caused by a group of moulds known as mucormycetes.
It is a viral disease, increasingly progressive, rapidly triggers in diabetic, immunocompromised and trauma
patients. Diabetic patients seem to have the classic rhinocerebral variant. Rhinocerebral mucormycosis
begins as a nasal cavity, paranasal sinus, and orbital soft tissue infection. In immunocompetent patients,
direct injection also induces cutaneous form. Cutaneous mucormycosis occurs in soft tissue and may infect
underlying tissues. Mucormycosis is more frequent in people with major underlying disorders such as
diabetic acidosis or acute leukaemia and those taking corticosteroids or cytotoxic drugs. This disease
occurs in patients by inhaling fungus spores. Mucormycosis occurs in clinical manifestations. Disseminated
mucormycosis is a rare form of mucormycosis, affecting individuals with compromised immune systems.
The disease travels to other areas of the body, thereby being prevalent. Brain, core, spleen, eyes, and other
organs are among the organs that may be affected. Mucormycosis is a dangerous infection that requires
antifungal drugs such as amphotericin B, posaconazole, or isavuconazole. This compilation addresses
conceptual background on medicines used to treat mucormycosis, especially in India.

Keywords: Mucormycosis, Amphotericin B, Diabetic acidosis, COVID-19.

How to cite : Setia A , Bhattacharya S , Mucormycosis and its implication in COVID-19. Indian J Pharm Pharmacol 2021;8(2):97-99

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.